Resectable Clear Cell Carcinoma of the Kidney
1 clinical trials · Condition
◉ Watch Resectable Clear Cell Carcinoma of the Kidney
| Record | Firm | Date |
|---|---|---|
| Cardenilimab Combined With Lenvatinib in Patients With Perioperative Resectable Clear Cell Renal Cell Carcinoma. (NCT06574412) | The First Hospital of Jilin University | 2024-09-01 |
Track Resectable Clear Cell Carcinoma of the Kidney automatically
Every clearance here is in the API, with alerts when new ones post.